Stem Cells - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Stem Cells Market is accounted for $23.73 billion in 2020 and is expected to reach $92.91 billion by 2028 growing at a CAGR of 18.6% during the forecast period. Evolving regulatory frameworks for stem cell therapeutics, an increase in the prevalence of chronic diseases worldwide, growing public-private investments, and funding in stem cell-based research are driving the market growth. However, the low acceptance rate for stem cell therapy treatments, significant operational costs associated with stem cell manufacturing and banking are hampering the growth of the market.
Stem cells possess the potential to develop into different types of cells within the body and are also used to make tissues and cells for treating several diseases. Stem cells are the autologous or allogenic cells that can grow into many types of cells in the in-vivo and in-vitro environment. Stem cell therapy is designed to aid the physician in performing medical treatment of neurodegenerative diseases, diabetes, and heart disease.
Based on the product, the induced pluripotent stem cells (iPSCs) segment is going to have lucrative growth during the forecast period due to the increasing investment for developing regenerative medicines using iPSC, ensured reproducibility and maintenance, capable of differentiation into all the cell types and high proliferative ability and the gaining importance of iPSCs in the treatment of various diseases. By geography, North America is going to have high growth during the forecast period owing to the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies.
Some of the key players profiled in the Stem Cells Market include Virgin Health Bank, ThermoGenesis Holdings, Stemcell Technologies, Caladrius Biosciences, Inc., RENEURON GROUP PLC, Precious Cells International Ltd, Celgene, Opexa Therapeutics, Mesoblast, Lineage Cell Therapeutics, Cellular Engineering Technologies, Seneca Biopharmaceuticals, Inc., Pluristem Therapeutics Inc., Biovault family and Astellas Pharma.
Therapies Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Stem cells possess the potential to develop into different types of cells within the body and are also used to make tissues and cells for treating several diseases. Stem cells are the autologous or allogenic cells that can grow into many types of cells in the in-vivo and in-vitro environment. Stem cell therapy is designed to aid the physician in performing medical treatment of neurodegenerative diseases, diabetes, and heart disease.
Based on the product, the induced pluripotent stem cells (iPSCs) segment is going to have lucrative growth during the forecast period due to the increasing investment for developing regenerative medicines using iPSC, ensured reproducibility and maintenance, capable of differentiation into all the cell types and high proliferative ability and the gaining importance of iPSCs in the treatment of various diseases. By geography, North America is going to have high growth during the forecast period owing to the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies.
Some of the key players profiled in the Stem Cells Market include Virgin Health Bank, ThermoGenesis Holdings, Stemcell Technologies, Caladrius Biosciences, Inc., RENEURON GROUP PLC, Precious Cells International Ltd, Celgene, Opexa Therapeutics, Mesoblast, Lineage Cell Therapeutics, Cellular Engineering Technologies, Seneca Biopharmaceuticals, Inc., Pluristem Therapeutics Inc., Biovault family and Astellas Pharma.
Therapies Covered:
- Auto Logic Stem Cell Therapy
- Syngeneic Stem Cell Therapy
- Allogeneic Stem Cell Therapy
- Adult Stem Cells (ASCs)
- Very Small Embryonic Like Stem Cells
- Natural Rosette Cells
- Induced Pluripotent Stem Cells (iPSCs)
- Human Embryonic Stem Cells (HESCs)
- Cell Acquisition
- Cell Production
- Expansion and Sub-Culture
- Cryopreservation
- Characterization Services
- Stem Cell Acquisition & Testing
- Drug Screening & Target Validation
- Molecular Biology
- Stem Cell Banking
- Drug Discovery and Development
- Regenerative Medicine
- Contract Research Organisation (CRO)
- Pharmaceutical/Biotechnology Companies
- Diseases Therapy
- Healthcare
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL STEM CELLS MARKET, BY THERAPY
5.1 Introduction
5.2 Auto Logic Stem Cell Therapy
5.3 Syngeneic Stem Cell Therapy
5.4 Allogeneic Stem Cell Therapy
6 GLOBAL STEM CELLS MARKET, BY PRODUCT
6.1 Introduction
6.2 Adult Stem Cells (ASCs)
6.2.1 Umbilical Cord Stem Cells/Fetal Stem Cells
6.2.2 Placenta Derived Stem Cells
6.2.3 Dental Stem Cells
6.2.4 Mesenchymal (Adipose?derived Stem Cells)
6.2.5 Hematopoietic
6.2.6 Epithelial/Skin
6.2.7 Neuronal Stem Cells ( Mouse/Rat Neural)
6.2.8 Dedifferentiated Fat (DFAT) Cells
6.3 Very Small Embryonic Like Stem Cells
6.4 Natural Rosette Cells
6.5 Induced Pluripotent Stem Cells (iPSCs)
6.6 Human Embryonic Stem Cells (HESCs)
7 GLOBAL STEM CELLS MARKET, BY TECHNOLOGY
7.1 Introduction
7.2 Cell Acquisition
7.2.1 Umbilical Blood Cord
7.2.2 Bone Marrow Harvest
7.2.3 Apheresis
7.3 Cell Production
7.3.1 Stem Cell Culture
7.3.2 Isolation
7.3.3 Somatic Nuclear Transfer / Therapeutic Cloning
7.3.4 In-vitro Fertilization
7.4 Expansion and Sub-Culture
7.5 Cryopreservation
8 GLOBAL STEM CELLS MARKET, BY SERVICES
8.1 Introduction
8.2 Characterization Services
8.2.1 Stem Cell Custom Services
8.2.2 Human Leukocyte Antigen (HLA) Typing Services
8.2.3 Stem Cell Custom Antibody Services
8.3 Stem Cell Acquisition & Testing
8.4 Drug Screening & Target Validation
8.5 Molecular Biology
8.6 Stem Cell Banking
9 GLOBAL STEM CELLS MARKET, BY APPLICATION
9.1 Introduction
9.2 Drug Discovery and Development
9.3 Regenerative Medicine
9.3.1 Soft Tissue Injuries and Wounds
9.3.2 Orthopedic Treatments
9.3.3 Hematology
9.3.4 Neurological Disorders
9.3.5 Liver Disorder
9.3.6 Incontinence
9.3.7 Oncology Disorders
9.3.8 Diabetes
9.3.9 Cardiovascular and Myocardial Infraction
10 GLOBAL STEM CELLS MARKET, BY APPLICATION AREA
10.1 Introduction
10.2 Contract Research Organisation (CRO)
10.3 Pharmaceutical/Biotechnology Companies
11 GLOBAL STEM CELLS MARKET, BY END USER
11.1 Introduction
11.2 Diseases Therapy
11.3 Healthcare
12 GLOBAL STEM CELLS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Virgin Health Bank
14.2 ThermoGenesis Holdings
14.3 Stemcell Technologies
14.4 Caladrius Biosciences, Inc.
14.5 RENEURON GROUP PLC
14.6 Precious Cells International Ltd
14.7 Celgene
14.8 Opexa Therapeutics
14.9 Mesoblast
14.10 Lineage Cell Therapeutics
14.11 Cellular Engineering Technologies
14.12 Seneca Biopharmaceuticals, Inc.
14.13 Pluristem Therapeutics Inc.
14.14 Biovault family
14.15 Astellas Pharma
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL STEM CELLS MARKET, BY THERAPY
5.1 Introduction
5.2 Auto Logic Stem Cell Therapy
5.3 Syngeneic Stem Cell Therapy
5.4 Allogeneic Stem Cell Therapy
6 GLOBAL STEM CELLS MARKET, BY PRODUCT
6.1 Introduction
6.2 Adult Stem Cells (ASCs)
6.2.1 Umbilical Cord Stem Cells/Fetal Stem Cells
6.2.2 Placenta Derived Stem Cells
6.2.3 Dental Stem Cells
6.2.4 Mesenchymal (Adipose?derived Stem Cells)
6.2.5 Hematopoietic
6.2.6 Epithelial/Skin
6.2.7 Neuronal Stem Cells ( Mouse/Rat Neural)
6.2.8 Dedifferentiated Fat (DFAT) Cells
6.3 Very Small Embryonic Like Stem Cells
6.4 Natural Rosette Cells
6.5 Induced Pluripotent Stem Cells (iPSCs)
6.6 Human Embryonic Stem Cells (HESCs)
7 GLOBAL STEM CELLS MARKET, BY TECHNOLOGY
7.1 Introduction
7.2 Cell Acquisition
7.2.1 Umbilical Blood Cord
7.2.2 Bone Marrow Harvest
7.2.3 Apheresis
7.3 Cell Production
7.3.1 Stem Cell Culture
7.3.2 Isolation
7.3.3 Somatic Nuclear Transfer / Therapeutic Cloning
7.3.4 In-vitro Fertilization
7.4 Expansion and Sub-Culture
7.5 Cryopreservation
8 GLOBAL STEM CELLS MARKET, BY SERVICES
8.1 Introduction
8.2 Characterization Services
8.2.1 Stem Cell Custom Services
8.2.2 Human Leukocyte Antigen (HLA) Typing Services
8.2.3 Stem Cell Custom Antibody Services
8.3 Stem Cell Acquisition & Testing
8.4 Drug Screening & Target Validation
8.5 Molecular Biology
8.6 Stem Cell Banking
9 GLOBAL STEM CELLS MARKET, BY APPLICATION
9.1 Introduction
9.2 Drug Discovery and Development
9.3 Regenerative Medicine
9.3.1 Soft Tissue Injuries and Wounds
9.3.2 Orthopedic Treatments
9.3.3 Hematology
9.3.4 Neurological Disorders
9.3.5 Liver Disorder
9.3.6 Incontinence
9.3.7 Oncology Disorders
9.3.8 Diabetes
9.3.9 Cardiovascular and Myocardial Infraction
10 GLOBAL STEM CELLS MARKET, BY APPLICATION AREA
10.1 Introduction
10.2 Contract Research Organisation (CRO)
10.3 Pharmaceutical/Biotechnology Companies
11 GLOBAL STEM CELLS MARKET, BY END USER
11.1 Introduction
11.2 Diseases Therapy
11.3 Healthcare
12 GLOBAL STEM CELLS MARKET, BY GEOGRAPHY
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa
13 KEY DEVELOPMENTS
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies
14 COMPANY PROFILING
14.1 Virgin Health Bank
14.2 ThermoGenesis Holdings
14.3 Stemcell Technologies
14.4 Caladrius Biosciences, Inc.
14.5 RENEURON GROUP PLC
14.6 Precious Cells International Ltd
14.7 Celgene
14.8 Opexa Therapeutics
14.9 Mesoblast
14.10 Lineage Cell Therapeutics
14.11 Cellular Engineering Technologies
14.12 Seneca Biopharmaceuticals, Inc.
14.13 Pluristem Therapeutics Inc.
14.14 Biovault family
14.15 Astellas Pharma
LIST OF TABLES
Table 1 Global Stem Cells Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Stem Cells Market Outlook, By Therapy (2019-2028) ($MN)
Table 3 Global Stem Cells Market Outlook, By Auto Logic Stem Cell Therapy (2019-2028) ($MN)
Table 4 Global Stem Cells Market Outlook, By Syngeneic Stem Cell Therapy (2019-2028) ($MN)
Table 5 Global Stem Cells Market Outlook, By Allogeneic Stem Cell Therapy (2019-2028) ($MN)
Table 6 Global Stem Cells Market Outlook, By Product (2019-2028) ($MN)
Table 7 Global Stem Cells Market Outlook, By Adult Stem Cells (ASCs) (2019-2028) ($MN)
Table 8 Global Stem Cells Market Outlook, By Umbilical Cord Stem Cells/Fetal Stem Cells (2019-2028) ($MN)
Table 9 Global Stem Cells Market Outlook, By Placenta Derived Stem Cells (2019-2028) ($MN)
Table 10 Global Stem Cells Market Outlook, By Dental Stem Cells (2019-2028) ($MN)
Table 11 Global Stem Cells Market Outlook, By Mesenchymal (Adipose?derived Stem Cells) (2019-2028) ($MN)
Table 12 Global Stem Cells Market Outlook, By Hematopoietic (2019-2028) ($MN)
Table 13 Global Stem Cells Market Outlook, By Epithelial/Skin (2019-2028) ($MN)
Table 14 Global Stem Cells Market Outlook, By Neuronal Stem Cells ( Mouse/Rat Neural) (2019-2028) ($MN)
Table 15 Global Stem Cells Market Outlook, By Dedifferentiated Fat (DFAT) Cells (2019-2028) ($MN)
Table 16 Global Stem Cells Market Outlook, By Very Small Embryonic Like Stem Cells (2019-2028) ($MN)
Table 17 Global Stem Cells Market Outlook, By Natural Rosette Cells (2019-2028) ($MN)
Table 18 Global Stem Cells Market Outlook, By Induced Pluripotent Stem Cells (iPSCs) (2019-2028) ($MN)
Table 19 Global Stem Cells Market Outlook, By Human Embryonic Stem Cells (HESCs) (2019-2028) ($MN)
Table 20 Global Stem Cells Market Outlook, By Technology (2019-2028) ($MN)
Table 21 Global Stem Cells Market Outlook, By Cell Acquisition (2019-2028) ($MN)
Table 22 Global Stem Cells Market Outlook, By Umbilical Blood Cord (2019-2028) ($MN)
Table 23 Global Stem Cells Market Outlook, By Bone Marrow Harvest (2019-2028) ($MN)
Table 24 Global Stem Cells Market Outlook, By Apheresis (2019-2028) ($MN)
Table 25 Global Stem Cells Market Outlook, By Cell Production (2019-2028) ($MN)
Table 26 Global Stem Cells Market Outlook, By Stem Cell Culture (2019-2028) ($MN)
Table 27 Global Stem Cells Market Outlook, By Isolation (2019-2028) ($MN)
Table 28 Global Stem Cells Market Outlook, By Somatic Nuclear Transfer / Therapeutic Cloning (2019-2028) ($MN)
Table 29 Global Stem Cells Market Outlook, By In-vitro Fertilization (2019-2028) ($MN)
Table 30 Global Stem Cells Market Outlook, By Expansion and Sub-Culture (2019-2028) ($MN)
Table 31 Global Stem Cells Market Outlook, By Cryopreservation (2019-2028) ($MN)
Table 32 Global Stem Cells Market Outlook, By Services (2019-2028) ($MN)
Table 33 Global Stem Cells Market Outlook, By Characterization Services (2019-2028) ($MN)
Table 34 Global Stem Cells Market Outlook, By Stem Cell Custom Services (2019-2028) ($MN)
Table 35 Global Stem Cells Market Outlook, By Human Leukocyte Antigen (HLA) Typing Services (2019-2028) ($MN)
Table 36 Global Stem Cells Market Outlook, By Stem Cell Custom Antibody Services (2019-2028) ($MN)
Table 37 Global Stem Cells Market Outlook, By Stem Cell Acquisition & Testing (2019-2028) ($MN)
Table 38 Global Stem Cells Market Outlook, By Drug Screening & Target Validation (2019-2028) ($MN)
Table 39 Global Stem Cells Market Outlook, By Molecular Biology (2019-2028) ($MN)
Table 40 Global Stem Cells Market Outlook, By Stem Cell Banking (2019-2028) ($MN)
Table 41 Global Stem Cells Market Outlook, By Application (2019-2028) ($MN)
Table 42 Global Stem Cells Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 43 Global Stem Cells Market Outlook, By Regenerative Medicine (2019-2028) ($MN)
Table 44 Global Stem Cells Market Outlook, By Soft Tissue Injuries and Wounds (2019-2028) ($MN)
Table 45 Global Stem Cells Market Outlook, By Orthopedic Treatments (2019-2028) ($MN)
Table 46 Global Stem Cells Market Outlook, By Hematology (2019-2028) ($MN)
Table 47 Global Stem Cells Market Outlook, By Neurological Disorders (2019-2028) ($MN)
Table 48 Global Stem Cells Market Outlook, By Liver Disorder (2019-2028) ($MN)
Table 49 Global Stem Cells Market Outlook, By Incontinence (2019-2028) ($MN)
Table 50 Global Stem Cells Market Outlook, By Oncology Disorders (2019-2028) ($MN)
Table 51 Global Stem Cells Market Outlook, By Diabetes (2019-2028) ($MN)
Table 52 Global Stem Cells Market Outlook, By Cardiovascular and Myocardial Infraction (2019-2028) ($MN)
Table 53 Global Stem Cells Market Outlook, By Application Area (2019-2028) ($MN)
Table 54 Global Stem Cells Market Outlook, By Contract Research Organisation (CRO) (2019-2028) ($MN)
Table 55 Global Stem Cells Market Outlook, By Pharmaceutical/Biotechnology Companies (2019-2028) ($MN)
Table 56 Global Stem Cells Market Outlook, By End User (2019-2028) ($MN)
Table 57 Global Stem Cells Market Outlook, By Diseases Therapy (2019-2028) ($MN)
Table 58 Global Stem Cells Market Outlook, By Healthcare (2019-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Table 1 Global Stem Cells Market Outlook, By Region (2019-2028) ($MN)
Table 2 Global Stem Cells Market Outlook, By Therapy (2019-2028) ($MN)
Table 3 Global Stem Cells Market Outlook, By Auto Logic Stem Cell Therapy (2019-2028) ($MN)
Table 4 Global Stem Cells Market Outlook, By Syngeneic Stem Cell Therapy (2019-2028) ($MN)
Table 5 Global Stem Cells Market Outlook, By Allogeneic Stem Cell Therapy (2019-2028) ($MN)
Table 6 Global Stem Cells Market Outlook, By Product (2019-2028) ($MN)
Table 7 Global Stem Cells Market Outlook, By Adult Stem Cells (ASCs) (2019-2028) ($MN)
Table 8 Global Stem Cells Market Outlook, By Umbilical Cord Stem Cells/Fetal Stem Cells (2019-2028) ($MN)
Table 9 Global Stem Cells Market Outlook, By Placenta Derived Stem Cells (2019-2028) ($MN)
Table 10 Global Stem Cells Market Outlook, By Dental Stem Cells (2019-2028) ($MN)
Table 11 Global Stem Cells Market Outlook, By Mesenchymal (Adipose?derived Stem Cells) (2019-2028) ($MN)
Table 12 Global Stem Cells Market Outlook, By Hematopoietic (2019-2028) ($MN)
Table 13 Global Stem Cells Market Outlook, By Epithelial/Skin (2019-2028) ($MN)
Table 14 Global Stem Cells Market Outlook, By Neuronal Stem Cells ( Mouse/Rat Neural) (2019-2028) ($MN)
Table 15 Global Stem Cells Market Outlook, By Dedifferentiated Fat (DFAT) Cells (2019-2028) ($MN)
Table 16 Global Stem Cells Market Outlook, By Very Small Embryonic Like Stem Cells (2019-2028) ($MN)
Table 17 Global Stem Cells Market Outlook, By Natural Rosette Cells (2019-2028) ($MN)
Table 18 Global Stem Cells Market Outlook, By Induced Pluripotent Stem Cells (iPSCs) (2019-2028) ($MN)
Table 19 Global Stem Cells Market Outlook, By Human Embryonic Stem Cells (HESCs) (2019-2028) ($MN)
Table 20 Global Stem Cells Market Outlook, By Technology (2019-2028) ($MN)
Table 21 Global Stem Cells Market Outlook, By Cell Acquisition (2019-2028) ($MN)
Table 22 Global Stem Cells Market Outlook, By Umbilical Blood Cord (2019-2028) ($MN)
Table 23 Global Stem Cells Market Outlook, By Bone Marrow Harvest (2019-2028) ($MN)
Table 24 Global Stem Cells Market Outlook, By Apheresis (2019-2028) ($MN)
Table 25 Global Stem Cells Market Outlook, By Cell Production (2019-2028) ($MN)
Table 26 Global Stem Cells Market Outlook, By Stem Cell Culture (2019-2028) ($MN)
Table 27 Global Stem Cells Market Outlook, By Isolation (2019-2028) ($MN)
Table 28 Global Stem Cells Market Outlook, By Somatic Nuclear Transfer / Therapeutic Cloning (2019-2028) ($MN)
Table 29 Global Stem Cells Market Outlook, By In-vitro Fertilization (2019-2028) ($MN)
Table 30 Global Stem Cells Market Outlook, By Expansion and Sub-Culture (2019-2028) ($MN)
Table 31 Global Stem Cells Market Outlook, By Cryopreservation (2019-2028) ($MN)
Table 32 Global Stem Cells Market Outlook, By Services (2019-2028) ($MN)
Table 33 Global Stem Cells Market Outlook, By Characterization Services (2019-2028) ($MN)
Table 34 Global Stem Cells Market Outlook, By Stem Cell Custom Services (2019-2028) ($MN)
Table 35 Global Stem Cells Market Outlook, By Human Leukocyte Antigen (HLA) Typing Services (2019-2028) ($MN)
Table 36 Global Stem Cells Market Outlook, By Stem Cell Custom Antibody Services (2019-2028) ($MN)
Table 37 Global Stem Cells Market Outlook, By Stem Cell Acquisition & Testing (2019-2028) ($MN)
Table 38 Global Stem Cells Market Outlook, By Drug Screening & Target Validation (2019-2028) ($MN)
Table 39 Global Stem Cells Market Outlook, By Molecular Biology (2019-2028) ($MN)
Table 40 Global Stem Cells Market Outlook, By Stem Cell Banking (2019-2028) ($MN)
Table 41 Global Stem Cells Market Outlook, By Application (2019-2028) ($MN)
Table 42 Global Stem Cells Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
Table 43 Global Stem Cells Market Outlook, By Regenerative Medicine (2019-2028) ($MN)
Table 44 Global Stem Cells Market Outlook, By Soft Tissue Injuries and Wounds (2019-2028) ($MN)
Table 45 Global Stem Cells Market Outlook, By Orthopedic Treatments (2019-2028) ($MN)
Table 46 Global Stem Cells Market Outlook, By Hematology (2019-2028) ($MN)
Table 47 Global Stem Cells Market Outlook, By Neurological Disorders (2019-2028) ($MN)
Table 48 Global Stem Cells Market Outlook, By Liver Disorder (2019-2028) ($MN)
Table 49 Global Stem Cells Market Outlook, By Incontinence (2019-2028) ($MN)
Table 50 Global Stem Cells Market Outlook, By Oncology Disorders (2019-2028) ($MN)
Table 51 Global Stem Cells Market Outlook, By Diabetes (2019-2028) ($MN)
Table 52 Global Stem Cells Market Outlook, By Cardiovascular and Myocardial Infraction (2019-2028) ($MN)
Table 53 Global Stem Cells Market Outlook, By Application Area (2019-2028) ($MN)
Table 54 Global Stem Cells Market Outlook, By Contract Research Organisation (CRO) (2019-2028) ($MN)
Table 55 Global Stem Cells Market Outlook, By Pharmaceutical/Biotechnology Companies (2019-2028) ($MN)
Table 56 Global Stem Cells Market Outlook, By End User (2019-2028) ($MN)
Table 57 Global Stem Cells Market Outlook, By Diseases Therapy (2019-2028) ($MN)
Table 58 Global Stem Cells Market Outlook, By Healthcare (2019-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
